PIK3CA‐H1047R mammary tumors showed strong activation of phosphorylated AKT, phosphorylated Gsk3‐β, cyclin D1, and activated β‐catenin compared to tumors from Her‐2 transgenic mice (Fig. 2A). The gene discussed is PIK3CA; the disease is breast cancer.